Objective: To evaluate the clinical safety and practicability of the closed thoracic drainage device after esophageal cancer surgery, so as to reduce the postoperative pain and shorten the length of the hospital stay,speed up the postoperative recovery of the patients.
Methods: A retrospective analysis of patients who underwent minimally invasive surgery for esophageal cancer in the Second Department of Surgery, General Hospital of Ningxia Medical University from January 2017 to December 2019. Among them, 44 and 59 patients underwent central venous catheter thoracic drainage and traditional closed thoracic drainage, respectively. Recorded data included postoperative pleural drainage, postoperative extubation time, postoperative complications (postoperative encapsulated pleural effusion, postoperative subcutaneous emphysema, postoperative atelectasis, postoperative pneumothorax, postoperative pulmonary infection, postoperative anastomotic leakage), catheter re-insertion after extubation, postoperative hospital stay,postoperative drainage tube healing time,and postoperative pain score, etc.
Results: There was no statistical difference in the postoperative chest drainage (d1) (547.72 ± 64.66 & 536.27 ± 84.67ml), postoperative extubation time (7.61 ± 0.92 & 7.53 ± 1.02min), or postoperative complications between the experimental group and the control group (p > 0.05). Postoperative thoracic drainage (d2-d5), postoperative hospital stay (11.75 ± 2.02 & 13.03 ± 1.29days), drainage tube healing time (5.64 ± 1.12 & 14.02 ± 1.32days), and postoperative pain scores were significantly different between the two groups of esophageal cancer patients (p < 0.05).
Conclusion: The central venous catheter used for thoracic drainage is not only safe and reliable, but also greatly reduces postoperative pain and discomfort of patients, and accelerates postoperative recovery of patients. Therefore, it conforms to the concept of enhanced recovery after surgery,an disworthy of clinical application.